Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (601-610 of 869) with videos related to

Pageof 87
Sort By:
Ebiomedicine|March 28, 2022
Indirubin-3'-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myelomaZhen Yu, Xiaojing Wei, Lanting Liu, et al.
Frontiers in Immunology|September 14, 2020
Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma CellsChen Zhu, Zhili Song, Anlai Wang, et al.
The Lancet. Oncology|September 24, 2013
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind studyMeletios Dimopoulos, David S Siegel, Sagar Lonial, et al.
Blood Advances|December 5, 2020
Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data HubWilliam A Wood, Donna S Neuberg, J Colton Thompson, et al.
Blood|February 27, 2014
Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myelomaYu-Tzu Tai, Patrick A Mayes, Chirag Acharya, et al.
Molecular Cancer Therapeutics|May 20, 2016
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple MyelomaNicola Amodio, Maria Angelica Stamato, Anna Maria Gullà, et al.
Blood Advances|October 21, 2021
ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematologyWilliam A Wood, Peter Marks, Robert M Plovnick, et al.
Oncogene|August 11, 2005
FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignanciesJing Chen, Benjamin H Lee, Ifor R Williams, et al.
Blood|April 30, 2009
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myelomaAldo M Roccaro, Antonio Sacco, Brian Thompson, et al.
Blood|December 17, 2008
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemiaAldo M Roccaro, Antonio Sacco, Changzhong Chen, et al.
Pageof 87

Showing results (601-610 of 869) with videos related to

Sort By:
Pageof 87
Ebiomedicine|March 28, 2022
Indirubin-3'-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myelomaZhen Yu, Xiaojing Wei, Lanting Liu, et al.
Frontiers in Immunology|September 14, 2020
Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma CellsChen Zhu, Zhili Song, Anlai Wang, et al.
The Lancet. Oncology|September 24, 2013
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind studyMeletios Dimopoulos, David S Siegel, Sagar Lonial, et al.
Blood Advances|December 5, 2020
Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data HubWilliam A Wood, Donna S Neuberg, J Colton Thompson, et al.
Blood|February 27, 2014
Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myelomaYu-Tzu Tai, Patrick A Mayes, Chirag Acharya, et al.
Molecular Cancer Therapeutics|May 20, 2016
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple MyelomaNicola Amodio, Maria Angelica Stamato, Anna Maria Gullà, et al.
Blood Advances|October 21, 2021
ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematologyWilliam A Wood, Peter Marks, Robert M Plovnick, et al.
Oncogene|August 11, 2005
FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignanciesJing Chen, Benjamin H Lee, Ifor R Williams, et al.
Blood|April 30, 2009
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myelomaAldo M Roccaro, Antonio Sacco, Brian Thompson, et al.
Blood|December 17, 2008
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemiaAldo M Roccaro, Antonio Sacco, Changzhong Chen, et al.
Pageof 87